A Potential Case of Acute Ketamine Withdrawal: Clinical Implications for the Treatment of Refractory Depression

被引：7
|
作者：
Roxas, Nichole [1 ]
Ahuja, Chaarushi [1 ]
Isom, Jessica [1 ]
Wilkinson, Samuel T. [1 ]
Capurso, Noah [1 ]
机构：
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06508 USA
来源：
AMERICAN JOURNAL OF PSYCHIATRY | 2021年 / 178卷 / 07期
关键词：
STAR-ASTERISK-D; ANTIDEPRESSANT;
D O I：
10.1176/appi.ajp.2020.20101480
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
[No abstract available]
引用
收藏
页码：588 / 591
页数：4
相关论文
共 50 条
  • [41] Intravenous ketamine for the subacute treatment of refractory chronic migraine: case series
    Mazuera, S.
    Lipton, R.
    Ashina, S.
    CEPHALALGIA, 2015, 35 : 26 - 27
  • [42] Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series
    Clinton Lauritsen
    Santiago Mazuera
    Richard B. Lipton
    Sait Ashina
    The Journal of Headache and Pain, 2016, 17
  • [43] Acute and Prolonged Antidepressant Effects of Ketamine in Treatment-Resistant Depression
    Phillips, Jennifer
    Birmingham, Meagan
    Hatchard, Taylor
    Norris, Sandhaya
    Talbot, Jeanne
    Ortiz, Abigail
    Blier, Pierre
    NEUROPSYCHOPHARMACOLOGY, 2017, 42 : S189 - S190
  • [44] Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression
    Steven Pennybaker
    Brian J. Roach
    Susanna L. Fryer
    Anusha Badathala
    Art W. Wallace
    Daniel H. Mathalon
    Tobias F. Marton
    Psychopharmacology, 2021, 238 : 3229 - 3237
  • [45] Subanesthetic ketamine infusions for suicide ideation in patients with bipolar and unipolar treatment refractory depression
    Kang, Melody J. Y.
    Kulcar, Eugenia
    Chandrasena, Ranjith
    Anjum, Mah-Rukh
    Fairbairn, Jonathan
    Hawken, Emily R.
    Vazquez, Gustavo H.
    PSYCHIATRY RESEARCH, 2021, 296
  • [46] Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
    Garel, Nicolas
    Greenway, Kyle T. T.
    Dinh-Williams, Le-Anh L.
    Thibault-Levesque, Julien
    Jutras-Aswad, Didier
    Turecki, Gustavo
    Rej, Soham
    Richard-Devantoy, Stephane
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (12) : 1769 - 1777
  • [47] Age affects temporal response, but not durability, to serial ketamine infusions for treatment refractory depression
    Pennybaker, Steven
    Roach, Brian J.
    Fryer, Susanna L.
    Badathala, Anusha
    Wallace, Art W.
    Mathalon, Daniel H.
    Marton, Tobias F.
    PSYCHOPHARMACOLOGY, 2021, 238 (11) : 3229 - 3237
  • [48] Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
    Nicolas Garel
    Kyle T. Greenway
    Lê-Anh L. Dinh-Williams
    Julien Thibault-Levesque
    Didier Jutras-Aswad
    Gustavo Turecki
    Soham Rej
    Stephane Richard-Devantoy
    Neuropsychopharmacology, 2023, 48 : 1769 - 1777
  • [49] THYROID-DYSFUNCTION IN REFRACTORY DEPRESSION - IMPLICATIONS FOR PATHOPHYSIOLOGY AND TREATMENT
    HOWLAND, RH
    JOURNAL OF CLINICAL PSYCHIATRY, 1993, 54 (02) : 47 - 54
  • [50] Comparative Effectiveness of Intravenous Ketamine and Intranasal Esketamine in Clinical Practice Among Patients With Treatment-Refractory Depression: An Observational Study
    Singh, Balwinder
    Kung, Simon
    Pazdernik, Vanessa
    Schak, Kathryn M.
    Geske, Jennifer
    Schulte, Phillip J.
    Frye, Mark A.
    Vande Voort, Jennifer
    JOURNAL OF CLINICAL PSYCHIATRY, 2023, 84 (02)
12345